tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Nuvectis Pharma reports Q2 EPS (30c) vs. (26c) last year
PremiumThe FlyNuvectis Pharma reports Q2 EPS (30c) vs. (26c) last year
2M ago
Strategic Pipeline Reprioritization and Promising Clinical Progress Drive Buy Rating for Nuvectis Pharma
Premium
Ratings
Strategic Pipeline Reprioritization and Promising Clinical Progress Drive Buy Rating for Nuvectis Pharma
2M ago
Nuvectis Pharma price target lowered to $10 from $15 at H.C. Wainwright
Premium
The Fly
Nuvectis Pharma price target lowered to $10 from $15 at H.C. Wainwright
2M ago
Nuvectis Pharma’s NXP900 shows positive drug interaction results in lung cancer
PremiumThe FlyNuvectis Pharma’s NXP900 shows positive drug interaction results in lung cancer
3M ago
Nuvectis Pharma Approves Proposals at Annual Meeting
Premium
Company Announcements
Nuvectis Pharma Approves Proposals at Annual Meeting
4M ago
Nuvectis Pharma Launches New $60M Stock Offering Program
Premium
Company Announcements
Nuvectis Pharma Launches New $60M Stock Offering Program
5M ago
Promising Developments in Nuvectis Pharma’s NXP900 Drive Buy Rating
PremiumRatingsPromising Developments in Nuvectis Pharma’s NXP900 Drive Buy Rating
5M ago
Nuvectis Pharma price target raised to $15 from $11 at H.C. Wainwright
Premium
The Fly
Nuvectis Pharma price target raised to $15 from $11 at H.C. Wainwright
5M ago
Nuvectis Pharma initiated with a Buy at Maxim
Premium
The Fly
Nuvectis Pharma initiated with a Buy at Maxim
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100